Identify psychological risk factors for PPBCT that may be targeted in preventive interventions Background Persistent pain after breast cancer treatment (PPBCT) affects 25% to 60% of patients treated for breast cancer, 1 may persist for
Search Results
Mathias Kvist Mejdahl, Birgitte Goldschmidt Mertz, Pernille Envold Bidstrup, and Kenneth Geving Andersen
Monira Alwhaibi, Usha Sambamoorthi, Suresh Madhavan, Thomas Bias, Kimberly Kelly, and James Walkup
). These dimensions are an individual's physical make-up, social support, access to care, health behaviors, psychological factors, biological risk factors, treatment factors, community resources, and geographic region. Methods Data Source SEER
Arjun Gupta, Raseen Tariq, Ryan D. Frank, Gary W. Jean, Muhammad S. Beg, Darrell S. Pardi, David H. Johnson, and Sahil Khanna
, prevention strategies, and newer treatment modalities for CDI. 4 – 9 Patients with cancer are particularly vulnerable to CDI, which is attributed to traditional risk factors such as age; cancer itself; hospitalization and health care exposure; chemotherapy
Cocav A. Engman and Leo R. Zacharski
responsible for the content and editorial decisions regarding this manuscript. References 1. Heit JA Silverstein MD Mohr DN . Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study . Arch Intern
Anurag Saraf, Hannah J. Roberts, Jennifer Y. Wo, and Aparna R. Parikh
enlarged lateral nodes. Among enrolled patients, more than half had either mesorectal fascia involvement or cN2 disease, with 60% having ≥2 high-risk factors and 30% having ≥3 high-risk factors. The primary endpoint of 3-year disease-related treatment
Francis P. Worden and Huan Ha
risk factor for the increase in incidence of tonsillar cancer . Int J Cancer 2006 ; 119 : 2620 – 2623 . 9. D'Souza G Kreimer AR Viscidi R . Case-control study of human papillomavirus and oropharyngeal cancer . N Engl J Med 2007 ; 356
Margaret R. O'Donnell, Camille N. Abboud, Jessica Altman, Frederick R. Appelbaum, Steven E. Coutre, Lloyd E. Damon, James M. Foran, Salil Goorha, Lori J. Maness, Guido Marcucci, Peter Maslak, Michael M. Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. Stone, Stephen A. Strickland, Martin S. Tallman, and Eunice S. Wang
. The panel has focused on outlining reasonable treatment options based on recent clinical trials and data from basic science, which may identify new risk factors and treatment approaches. In some areas, panel members have divergent opinions about the
Himani Aggarwal, Li Li, Gebra Cuyun Carter, Kathy Fraeman, and Ariel Berger
risk factors included alcohol use, diabetes, and distant metastases. Conclusions: HPV-positive status was associated with a decreased risk of mortality among OPC patients in this study. Despite the small sample size and potential violation of
Scott Cooper, Mohammed Zaher, and Gregory Diorio
.S. Surveillance, Epidemiology, and End Results registry (SEER). Clinical identification of risk factors for adverse outcomes will allow for patient-specific counseling on prognosis and intervention. Methods: Population-based data from SEER 18 was used to assess
Chunkit Fung, Sophie D. Fossa, Clair J. Beard, and Lois B. Travis
known cancer risk factors, 31 such as smoking. 11 Chamie et al. 30 conducted a retrospective study to determine if patients with stage I nonseminoma who forewent RPLND had higher risks of SMN than those who underwent RPLND, with the assumption that
